Effect of direct-acting antiviral drugs on portal circulation hemodynamics in cirrhotic patients infected with HCV

Abstract Background Liver cirrhosis (LC) is the most common cause of portal hypertension. In chronic hepatitis C patients who are treated with direct-acting antiviral therapy (DAAS), the progression of cirrhosis can be reversed with treatment. Portal hypertension is also expected to improve with a v...

Descripció completa

Dades bibliogràfiques

Autors principals:	Alshymaa A. Hassnine, Wail Soliman, Amr M. Elsayed, Mahmoud M. Higazi, Mery Saied, Ehab M. Abdelraheem
Format:	Artigo
Idioma:	Inglês
Publicat:	SpringerOpen 2022-02-01
Col·lecció:	Egyptian Liver Journal
Matèries:	Chronic HCV Liver cirrhosis Direct antiviral agents (DAAS) Portal hypertension Doppler and duplex examination
Accés en línia:	https://doi.org/10.1186/s43066-022-00181-4
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!